World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
29980
World Ranking
12202
National Ranking
661

Overview

Claus Belka is affiliated with Ludwig-Maximilians-Universität München in Germany and has contributed extensively to the field of medicine, with a particular focus on pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, radiation, oncology, and surgery.

The scientist's research spans several main topics, including advanced radiotherapy techniques, radiomics and machine learning in medical imaging, medical imaging techniques and applications, lung cancer diagnosis and treatment, glioma diagnosis and treatment, lung cancer treatments and mutations, and radiation therapy and dosimetry.

Frequent publication venues for Claus Belka include:

  • Radiotherapy and Oncology
  • Radiation Oncology
  • Physics in Medicine and Biology
  • Cancers
  • Clinical and Translational Radiation Oncology

Among their recent notable papers are:

  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement, 2020, Radiotherapy and Oncology
  • Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review, 2020, Radiation Oncology
  • Current status and recent advances in reirradiation of glioblastoma, 2021, Radiation Oncology
  • ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma, 2023, Radiotherapy and Oncology
  • First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients, 2020, Journal of Nuclear Medicine

Claus Belka frequently collaborates with several co-authors including Maximilian Niyazi, Stefanie Corradini, Guillaume Landry, Chukwuka Eze, and Christopher Kurz.

Best Publications

  • Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal

    Kirsten Lauber;Erwin Bohn;Stefan Martin Kröber;Yi Jin Xiao

  • Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

    Michael Orth;Michael Orth;Philipp Metzger;Philipp Metzger;Sabine Gerum;Julia Mayerle

  • A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

    W Budach;T Hehr;V Budach;C Belka

  • Radiation induced CNS toxicity – molecular and cellular mechanisms

    C Belka;W Budach;R D Kortmann;M Bamberg

  • Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

    Wilfried Ernst Erich Eberhardt;Christoph Pöttgen;Thomas Christoph Gauler;Godehard Friedel

  • ESTRO-ACROP guideline "target delineation of glioblastomas"

    Maximilian Niyazi;Michael Brada;Anthony J Chalmers;Stephanie E Combs

  • Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.

    Ingo H Engels;Ania Stepczynska;Christopher Stroh;Kirsten Lauber

  • Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial

    Rolf D. Issels;Lars H. Lindner;Jaap Verweij;Rüdiger Wessalowski

  • MR-guidance in clinical reality: Current treatment challenges and future perspectives

    S. Corradini;F. Alongi;N. Andratschke;C. Belka

  • CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)

    Panagiotis Balermpas;Panagiotis Balermpas;Franz Rödel;Franz Rödel;Claus Rödel;Claus Rödel;Mechthild Krause

  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.

    Matthias Guckenberger;Claus Belka;Andrea Bezjak;Jeffrey Bradley

  • Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo

    Andrea Renz;Wolfgang E. Berdel;Michael Kreuter;Claus Belka

  • Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells

    Ralf R. Schumann;Claus Belka;Claus Belka;Dirk Reuter;Dirk Reuter;Norbert Lamping;Norbert Lamping

  • Dying cell clearance and its impact on the outcome of tumor radiotherapy.

    Kirsten Lauber;Anne Ernst;Michael Orth;Martin Herrmann

  • Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids

    Albrecht Lepple-Wienhues;Claus Belka;Tilmann Laun;Andreas Jekle

  • Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences.

    Nikko Brix;Anna Tiefenthaller;Heike Anders;Claus Belka

  • Guardians of cell death: the Bcl-2 family proteins

    Peter T Daniel;Klaus Schulze-Osthoff;Claus Belka;Dilek Güner

  • A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling.

    Stefan Leger;Stefan Leger;Alex Zwanenburg;Karoline Pilz;Fabian Lohaus

  • Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

    Ulrich Herrlinger;Niklas Schäfer;Joachim P. Steinbach;Astrid Weyerbrock

  • Current concepts in clinical radiation oncology.

    Michael Orth;Kirsten Lauber;Maximilian Niyazi;Anna A. Friedl

Frequent Co-Authors

Verena Jendrossek
Verena Jendrossek University of Duisburg-Essen
Michael Bamberg
Michael Bamberg University of Tübingen
Kirsten Lauber
Kirsten Lauber Ludwig-Maximilians-Universität München
Peter Bartenstein
Peter Bartenstein Ludwig-Maximilians-Universität München
Claus Rödel
Claus Rödel Goethe University Frankfurt
Christian G. Stief
Christian G. Stief Ludwig-Maximilians-Universität München
Amir Abdollahi
Amir Abdollahi National Center for Tumor Diseases
Jürgen Debus
Jürgen Debus University Hospital Heidelberg
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Michael H. Baumann
Michael H. Baumann National Institute on Drug Abuse

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine often means considering related fields and alternative educational pathways. Many students are now pursuing online degrees to save time and reduce costs while gaining vital healthcare qualifications.

For those interested in becoming advanced practice nurses, several affordable np programs are available online, making it easier to achieve this career step without a heavy financial burden.

If you are aiming to start your nursing career or advance with a Bachelor of Science in Nursing, look into the cheapest online bsn programs for flexible and budget-friendly options.

Nurses seeking top-tier qualifications can pursue a doctorate affordably through the cheapest dnp online program.

For registered nurses seeking to boost their credentials, many rn to bsn online programs offer convenient ways to gain a BSN and open new career doors.

These online degree options provide accessible, affordable, and flexible pathways for those passionate about healthcare and keen to expand their career options within or adjacent to the medical field.

Best Scientists Citing Claus Belka

Trending Scientists